Univest
Univest
  • Markets

Ajanta Pharma (AJANTPHARM) Share Price Rises 2.40% to Rs 3,363.20: Price Rise Analysis

  • September 7, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Ajanta Pharma Share Price
Ajanta Pharma Ltd. (AJANTPHARM) share price rose to Rs 3,363.2 today, up 2.4% from the previous close. Market cap was Rs 41,041.54 crore.

Ajanta Pharma Share Price is trading at Rs 3,363.20 as of 1:22 PM IST on 16 November 2026, up 2.40% from the previous close of Rs 3,284.40. The company has a market capitalisation of Rs 41,041.54 crore, and the Ajanta Pharma share price rise is the event behind this update.

Univest data confirms the move itself, though no company-specific trigger has been identified. This Ajanta Pharma stock analysis therefore sticks to what the numbers show: the intraday range, a P/E ratio of 32.50, a P/B ratio of 8.45, return on equity of 25.42% and return on capital employed of 32.67%.

Table of Contents

Toggle
  • Ajanta Pharma Share Price Today: Price Action Analysis
  • Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Ajanta Pharma
  • About Ajanta Pharma
  • Frequently Asked Questions
    • Why is Ajanta Pharma share price rising today?
    • What is the Ajanta Pharma share price today?
    • What is the market capitalisation of Ajanta Pharma?
    • What are the day high and day low of Ajanta Pharma Share Price?
    • What is the P/E ratio of Ajanta Pharma?
    • What are the ROE and ROCE of Ajanta Pharma?
    • What are the EPS and book value of Ajanta Pharma?
    • What is the dividend yield of Ajanta Pharma?
  • Track Ajanta Pharma Share Price on Univest

Ajanta Pharma Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 3,363.2
Previous Close Rs 3,284.4
Today's Move Rs 78.8 (+2.4%)
Open Rs 3,293.8
High Rs 3,402
Low Rs 3,284.4
Market Capitalisation Rs 41,041.54 crore
Market Cap Category Large Cap

Ajanta Pharma Ltd. (AJANTPHARM) rose to Rs 3,363.2 from the previous close of Rs 3,284.4, a move of Rs 78.8 or 2.4%. The stock opened at Rs 3,293.8, reached a high of Rs 3,402, recorded a low of Rs 3,284.4.

Ajanta Pharma Share Price Today stands at Rs 3,363.20, a gain of Rs 78.80 or 2.40% over the previous close of Rs 3,284.40. The stock opened at Rs 3,293.80 and has moved between Rs 3,284.40 and Rs 3,402.00 so far, as of 16 November 2026 at 1:22:47 PM IST.

The day open of Rs 3,293.80 was Rs 9.40 above the previous close. The day low of Rs 3,284.40 is exactly the previous close, so the Ajanta Pharma stock has not traded below its prior-session level at any point today. The day high of Rs 3,402.00 sits Rs 38.80 above the current price.

This Ajanta Pharma stock performance update also notes the company’s market capitalisation of Rs 41,041.54 crore, which describes size and not quality. With the price action mapped, the next step is Ajanta Pharma fundamental analysis.

Ajanta Pharma Ltd. (AJANTPHARM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 41,041.54 crore
P/E Ratio 32.5x
P/B Ratio 8.45x
ROE 25.42%
ROCE 32.67%
EPS Rs 101.06
Book Value Per Share Rs 388.78
Dividend Yield 0.85%

Ajanta Pharma Ltd. (AJANTPHARM) fundamental metrics show P/E 32.5x, P/B 8.45x, ROE 25.42%, ROCE 32.67%. Read together, these ratios describe the company’s position rather than a recommendation.

Ajanta Pharma Ltd. has a market capitalisation of Rs 41,041.54 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 32.5x, P/B at 8.45x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.42% and ROCE of 32.67%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 101.06, book value per share of Rs 388.78, dividend yield of 0.85%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 32.5x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 8.45x
Benchmark Median P/B 2.9x
Company ROE 25.42%
Benchmark Median ROE 10.98%
Company ROCE 32.67%
Benchmark Median ROCE 12.63%
Company Market Capitalisation Rs 41,041.54 crore
Benchmark Median Market Cap Rs 698.04 crore

Ajanta Pharma Ltd. (AJANTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 32.5x, which is above the benchmark median of 30.93x, a difference of +5.08%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Ajanta Pharma Ltd. (AJANTPHARM) has a ROE of 25.42%, which is above the benchmark median of 10.98%, a difference of +131.51%. Ajanta Pharma Ltd. (AJANTPHARM) has a ROCE of 32.67%, which is above the benchmark median of 12.63%, a difference of +158.67%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Ajanta Pharma Ltd. (AJANTPHARM) has a P/E ratio of 32.5x compared with the displayed peer median of 83.49x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 25.42% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 32.67% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ajanta Pharma Ltd. (AJANTPHARM) has a market capitalisation of Rs 41,041.54 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Ajanta Pharma

  • Price action: Ajanta Pharma Share Price is up 2.40% at Rs 3,363.20 against a previous close of Rs 3,284.40.
  • Intraday range: the stock has moved between Rs 3,284.40 and Rs 3,402.00 today.
  • Returns: ROE of 25.42% and ROCE of 32.67% are above the industry medians of 10.98% and 12.63%.
  • Valuation: a P/E ratio of 32.50 against an industry median of 30.93 and a P/B ratio of 8.45 against 2.90.
  • Peer position: ROCE is the highest among the five listed peers shown in the comparison.

About Ajanta Pharma

Ajanta Pharma Ltd. trades under the symbol AJANTPHARM and is classified in the Healthcare sector under the Pharmaceuticals & Drugs industry. Its market capitalisation of Rs 41,041.54 crore places it well above the industry median of Rs 698.04 crore, and its ROE and ROCE are above the industry medians shown in the sector section.

For readers following Ajanta Pharma company news, the sector and peer sections above show how the business is positioned within a benchmark of 205 companies in the same industry.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Ajanta Pharma share price rising today?

Ans. Univest data confirms the move itself, though no company-specific trigger has been identified. Ajanta Pharma Share Price is at Rs 3,363.20, up 2.40% from the previous close of Rs 3,284.40, with a market capitalisation of Rs 41,041.54 crore.

What is the Ajanta Pharma share price today?

Ans. Ajanta Pharma Share Price was at Rs 3,363.20 as of 1:22:47 PM IST on 16 November 2026. That is a gain of Rs 78.80, or 2.40%, over the previous close of Rs 3,284.40, after an open at Rs 3,293.80.

What is the market capitalisation of Ajanta Pharma?

Ans. Ajanta Pharma has a market capitalisation of Rs 41,041.54 crore at the current Ajanta Pharma Share Price of Rs 3,363.20. The industry median is Rs 698.04 crore and the average is Rs 14,540.61 crore across the benchmark companies.

What are the day high and day low of Ajanta Pharma Share Price?

Ans. Ajanta Pharma Share Price has touched a high of Rs 3,402.00 and a low of Rs 3,284.40 today. The day low equals the previous close of Rs 3,284.40, and the stock now trades at Rs 3,363.20.

What is the P/E ratio of Ajanta Pharma?

Ans. The P/E ratio of Ajanta Pharma is 32.50, against an industry median of 30.93 and an industry average of 52.22. The P/B ratio is 8.45, compared with an industry median of 2.90 and an average of 3.43.

What are the ROE and ROCE of Ajanta Pharma?

Ans. Ajanta Pharma reports ROE of 25.42% and ROCE of 32.67%. The industry median ROE is 10.98% and the median ROCE is 12.63%, so both returns are above the benchmark medians at the current Ajanta Pharma Share Price.

What are the EPS and book value of Ajanta Pharma?

Ans. Ajanta Pharma has an EPS of Rs 101.06 and a book value of Rs 388.78 per share. EPS shows earnings per share, while book value shows the accounting net worth behind each share, next to the Ajanta Pharma Share Price of Rs 3,363.20.

What is the dividend yield of Ajanta Pharma?

Ans. The dividend yield of Ajanta Pharma is 0.85%. It reflects the historical payout relative to the current price of Rs 3,363.20 and says nothing certain about future payouts, so it is one input in the wider Ajanta Pharma fundamental analysis.

Track Ajanta Pharma Share Price on Univest

Use Ajanta Pharma Ltd. (AJANTPHARM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track the live Ajanta Pharma Share Price on Univest, along with fundamental ratios, 52-week levels and market insights for the stock. Univest brings the price, the valuation multiples and the sector benchmark together so that the Ajanta Pharma stock update can be followed in one place as the session continues.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply